Related Experiment Videos
Brain metastases in lung cancer
1University of Colorado Health Sciences Center, Department of Radiation Oncology, 1663 N. Ursula Street, Box F-706, Suite 1032, Aurora, CO 80010-0510, USA. laurie.gaspar@uchsc.edu
Expert Review of Anticancer Therapy
|April 2, 2004
Summary
Brain metastases from lung cancer, including non-small cell lung cancer and small cell lung cancer, are a significant research focus. This review covers prognostic factors and current treatments like chemotherapy, surgery, and radiation therapy.
Area of Science:
- Oncology
- Neurology
Background:
- Brain metastases are a common complication of lung cancer, particularly non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
- The brain is a frequent site of disease progression, sometimes as the sole site of recurrence after treatment for advanced NSCLC.
- Outcomes and treatment approaches for lung cancer brain metastases can differ from those originating from other primary tumor types.
Purpose of the Study:
- To review prognostic factors for lung cancer brain metastases.
- To summarize current treatment modalities including chemotherapy, surgery, and radiation therapy.
Main Methods:
- Literature review of prognostic factors.
- Overview of established treatment strategies for brain metastases in lung cancer patients.
Main Results:
- Key prognostic indicators for brain metastases from lung cancer have been identified.
- Current treatment options encompass chemotherapy, surgical intervention, and various radiation therapy techniques.
Conclusions:
- Understanding prognostic factors is crucial for managing lung cancer brain metastases.
- A multimodal treatment approach combining systemic therapy, surgery, and radiation is often employed.